Perfuze announced today that it completed enrollment in its U.S. FDA investigational exemption (IDE) trial evaluating its ...

Orchestra BioMed (Nasdaq:OBIO) received FDA breakthrough device designation for its atrioventricular interval modulation ...

Biolinq has completed its pivotal trial and submitted its wearable biosensor to the FDA for regulatory review.

Axoft today announced preliminary results from the first-in-human clinical study of its implantable brain-computer interfaces ...

Field Medical announced that it closed a Series A financing round worth $40 million to support its pulsed field ablation (PFA) technology.

Zimmer Biomet (NYSE: ZBH) + Zimmer Biomet Holdings, Inc. $97.91 0.97% Open 98.134 Day High 98.429 52 Week High 133.6 52 Week ...

Abbott has launched a new Libre smartphone app for users of its popular FreeStyle Libre continuous glucose monitors.

Franklin Lakes, New Jersey-based BD says HemoSphere Alta becomes the most advanced hemodynamic monitoring technology ...

Q’Apel Medical announced that the FDA classified a voluntary recall of its 072 A System as Class I, the most serious kind.

The FDA shared an alert that BD (NYSE: BDX) and its Bard subsidiary warned customers of an issue with certain intravascular ...

Precision Neuroscience announced today that it received FDA 510(k) clearance for its Layer 7 cortical interface for BCI ...

CeriBell (Nasdaq:CBLL) announced today that it received FDA 510(k) clearance for its next-generation Ceribell Clarity ...